Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GS-840 enters phase II/III

June 14, 1996

Sankyo reports anti-HIV-1 oligodeoxyribonucleotides

June 14, 1996

Immunostimulating whole plant product undergoes clinical trials on AIDS patients

June 7, 1996

NSC-158393: Promising candidate for development as anti-AIDS drug

June 7, 1996

Unimed announces licensing agreement on its testosterone products

May 31, 1996

NSC-645793 and NSC-651016: Anti-HIV agents with potential as clinical candidates

May 31, 1996

Marketing agreement for trimetrexate glucuronate announced

May 31, 1996

European patent covering lamivudine issued

May 31, 1996

Positive results on cidofovir topical gel

May 31, 1996

Ritonavir granted scientific approval from CPMP

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...